These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy. Karat AB; Jeevaratnam A; Karat S; Rao PS Br Med J; 1970 Jan; 1(5690):198-200. PubMed ID: 4904935 [TBL] [Abstract][Full Text] [Related]
4. TREATMENT OF LEPROSY WITH B 663 APPRAISAL OF THE PILOT TRIAL AFTER THREE YEARS. BROWNE SG Lepr Rev; 1965 Jan; 36():13-5. PubMed ID: 14241912 [No Abstract] [Full Text] [Related]
5. THE ANTIMYCOBACTERIAL ACTIVITY OF B 663. BARRY VC; CONALTY ML Lepr Rev; 1965 Jan; 36():3-7. PubMed ID: 14241918 [No Abstract] [Full Text] [Related]
6. RED AND BLACK PIGMENTATION DEVELOPING DURING TREATMENT OF LEPROSY WITH 'B 663'. BROWNE SG Lepr Rev; 1965 Jan; 36():17-20. PubMed ID: 14241913 [No Abstract] [Full Text] [Related]
7. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy. Karat AB; Jeevaratnam A; Karat S; Rao PS Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472 [No Abstract] [Full Text] [Related]
8. NECROTIZING REACTIONS IN LEPROMATOUS LEPROSY. A CLINICAL AND HISTOLOGIC STUDY. WATERS MF; RIDLEY DS Int J Lepr; 1963; 31():418-36. PubMed ID: 14166267 [No Abstract] [Full Text] [Related]
9. Daily multidrug therapy for leprosy; results of a fourteen-year experience. de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752 [TBL] [Abstract][Full Text] [Related]
10. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage. Naafs B Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120 [No Abstract] [Full Text] [Related]
11. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)). Schulz EJ Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819 [No Abstract] [Full Text] [Related]
12. [Histoid leprosy with erythema nodosum leprosum]. Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700 [TBL] [Abstract][Full Text] [Related]
13. [Leprosy and the testis]. Rodríguez G; Abaúnza MC; Vargas EJ; López F Biomedica; 2012; 32(1):13-22. PubMed ID: 23235783 [TBL] [Abstract][Full Text] [Related]
14. Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy. Hastings RC; Trautman JR; Mansfield RE Dermatol Int; 1969; 8(1):21-7. PubMed ID: 5343403 [No Abstract] [Full Text] [Related]
15. Co-existent acquired perforating collagenosis and lepromatous leprosy with erythema nodosum leprosum: response to treatment. Gupta L; Singal A; Pandhi D; Sharma S Indian J Dermatol Venereol Leprol; 2011; 77(4):520-2. PubMed ID: 21727707 [No Abstract] [Full Text] [Related]
17. Histoid leprosy with erythema nodosum leprosum--a case report. Vasavi S; Reddy BS Indian J Lepr; 2012; 84(1):27-9. PubMed ID: 23077781 [TBL] [Abstract][Full Text] [Related]
18. Necrotic erythema nodosum leprosum with oral mucosal involvement. Swain JP; Soud A; Agarwal SK Indian J Lepr; 2008; 80(2):175-8. PubMed ID: 19425513 [TBL] [Abstract][Full Text] [Related]
19. Lepromatous leprosy in Saudi female from central region. al-Majed S J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1940331 [TBL] [Abstract][Full Text] [Related]
20. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy. Rodriguez JN; Abalos RM; Reich CV; Tolentino JG Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715 [No Abstract] [Full Text] [Related] [Next] [New Search]